William Blair has the equivalent of a buy rating on the stock, as do all 13 analysts offering coverage of the stock on FactSet. The bank is one of many expecting Viking to be a takeover target, given ...
Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver ...
Transplant rates and waitlist dropouts for women are now similar to those for men, yet some disparities still exist.
Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...
The presentation entitled “Pharmacokinetics, Safety and Efficacy of the Novel Non-bile Acid FXR Agonist FXR314 in Patients with Metabolic Dysfunction-Associated Steatohepatitis: Results from a Phase 2 ...
Daily Express US on MSN20h
Beer drinkers 'have worse diets than wine lovers', study findsA recent study has sounded the alarm for beer lovers, suggesting that their food choices might not be up to par with those ...
Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-ß) Agonist, was Well-tolerated with Significant Reductions in Liver Fat at Week 12 in Non-cirrhotic MASH Patients in the Ongoing ...
Since MELD 3.0 was implemented in July 2023, a higher proportion of women are now on the liver transplant waitlist, and ...
Psychosocial factors associated with liver transplant candidates’ placement on the waiting list were identified via large ...
Among 64 patients who received immune checkpoint inhibitors, 78% had downstaging of their liver tumor to within Milan ...
A recent study reveals that people who drink only beer tend to have poorer diets and health habits compared to those who ...
GlobalData on MSN1d
Resolution Therapeutics secures Spanish liver disease trial approvalDesigned to treat end-stage liver disease, the company has been granted permission from the Spanish authorities to expand its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback